The organization's bioethics committee called for a moratorium on germline editing and regulations on personal genomic testing.
The availability of consumer genomics services has also made it possible for adoptees to bypass state adoption laws, many of which restrict access to their records.
The test, called CancerIntercept Detect, is aimed at the early discovery of malignancies in asymptomatic people with an elevated risk of developing cancer, and can be ordered directly through Pathway and its online doctor network.
The company, called Helix, has received commitments for more than $100 million in financing and has signed on the Mayo Clinic and LabCorp as initial partners.
23andMe has seen a rebound in its ancestry testing business, and hopes that it will be able to return health information to US customers by the year end.
Thanks to a new array, NatGeo will now offer customers expanded Y chromosome and mtDNA analyses, setting it apart in a competitive consumer genomics market.
The collaboration will use AncestryDNA's databases, tools, and algorithms to investigate the genetics of families whose individuals live unusually long lives.
AncestryHealth is a new online resource that the family history company hopes will blossom into a larger business segment devoted exclusively to health.
Industry observers believe that Y chromosome sequencing services — until now the domain of advanced genetic genealogists and academics — could become more popular.
Kailos has launched a model where consumers can order testing without a doctor's prescription, but would need a doctor to view and interprest results.
A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.
The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.
University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.
In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.